Article Text
Controversy
Therapeutic cloning research and ethical oversight
Abstract
Cloning Trevor, a story about therapeutic cloning research, appeared in the June issue of The Atlantic Monthly. The story gives a human face to the people whom therapeutic cloning could benefit. It presents an argument for government funding and it puts the usual calls for a moratorium on embryonic stem cell research to allow for more debate, in a less favourable light. The story also highlights some problems with ethical oversight.
- therapeutic cloning
- advanced cell technology (ACT)
- adrenoleukodystrophy (ALD)
- government funded research
- private research
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- What happened to the stem cells?
- Is a consensus possible on stem cell research? Moral and political obstacles
- Reproductive cloning in humans and therapeutic cloning in primates: is the ethical debate catching up with the recent scientific advances?
- Adam’s fibroblast? The (pluri)potential of iPCs
- Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies
- The significance of induced pluripotent stem cells for basic research and clinical therapy
- Abortion and human nature
- Research Ethics, Science Policy, and Four Contexts for the Stem Cell Debate
- Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryos
- US scientists clone first human embryo